Research Peptide
Selank 10MG
$55.00
● In Stock
A 7-amino-acid synthetic tuftsin analog developed by the Russian Institute of Molecular Genetics, studied for anxiolytic, immunomodulatory, and cognitive effects without the sedation profile of benzodiazepines.
Purity
≥99.4%
Mol. Weight
751.87 g/mol
Amino Acid Sequence
Thr-Lys-Pro-Arg-Pro-Gly-Pro
Storage
Store lyophilized peptide at -20°C in a sealed vial away from light and moisture. After reconstitution with bacteriostatic water, keep refrigerated at 2–8°C and use within 30 days. Do not freeze reconstituted solution.
Certificate of Analysis
View third-party lab report · LOT #NP-SELANK-26
Selank is a synthetic heptapeptide analog of the endogenous immunopeptide tuftsin, developed at the Russian Institute of Molecular Genetics. It is approved in Russia as an intranasal anxiolytic and produces effects without the sedation profile of benzodiazepines. Reported research benefits: reduction of anxiety and stress-related behavior without sedation, tolerance, or withdrawal; improvements in working memory, attention, and learning; upregulation of hippocampal BDNF; stabilization of mood through enkephalinase inhibition; immunomodulation with enhanced macrophage activity and interferon production; antiviral activity in influenza models; and rebalancing of GABA-A receptor subunit expression associated with stress resilience.
Related Products
Retatrutide 30MG
Triple agonist — high-dose vial for extended studies.
Retatrutide 50MG
Triple agonist — bulk presentation for long-term protocols.
Tirzepatide 10MG
First-in-class dual GIP / GLP-1 receptor agonist.